Efficacy and Side Effects of Drugs Commonly Used for the Treatment of Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is the most common benign disease of the prostate gland and is caused by benign hyperplasia of the smooth muscle cells and stromal cells in this important gland. BPH is also the most common disease underlying lower urinary tract symptoms (LUTS). The incidence of BP...
Saved in:
Main Authors: | Zhao-Jun Yu (Author), Hai-Lan Yan (Author), Fang-Hua Xu (Author), Hai-Chao Chao (Author), Lei-Hong Deng (Author), Xiang-Da Xu (Author), Jian-Biao Huang (Author), Tao Zeng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of preoperative prostate volume on the improvement of lower urinary tract symptoms in patients with benign prostatic hyperplasia undergoing transurethral resection of prostate
by: Behzad Lotfi, et al.
Published: (2020) -
Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
by: Masumori N
Published: (2011) -
Bacteriological pattern of urinary tract infection in men with symptomatic benign prostatic hyperplasia at a tertiary hospital in Nigeria
by: Ngwu PE, et al.
Published: (2022) -
Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
by: Ulchaker JC, et al.
Published: (2017) -
Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
by: Zonglan Xie, et al.
Published: (2024)